Short-course combination treatment for experimental chronic Chagas disease

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects millions of people in the Americas and across the world leading to considerable morbidity and mortality. Current treatment options, benznidazole (BNZ) and nifurtimox, offer limited efficacy and often lead to adverse side eff...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Transl Med
Päätekijät: González, Silvia, Wall, Richard J., Thomas, John, Braillard, Stephanie, Brunori, Gino, Díaz, Isabel Camino, Cantizani, Juan, Carvalho, Sandra, Castañeda Casado, Pablo, Chatelain, Eric, Cotillo, Ignacio, Fiandor, Jose M., Francisco, Amanda Fortes, Grimsditch, David, Keenan, Martine, Kelly, John M., Kessler, Albane, Luise, Chiara, Lyon, Jon J., MacLean, Lorna, Marco, Maria, Martin, J. Julio, Martinez, Maria S., Paterson, Christy, Read, Kevin D., Santos-Villarejo, Angel, Zuccotto, Fabio, Wyllie, Susan, Miles, Tim J., De Rycker, Manu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2023
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7615676/
https://ncbi.nlm.nih.gov/pubmed/38091410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.adg8105
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia